|
Mean age (years)
|
35 (30 to 41)
|
40 (35 to 48)
|
43 (36 to 49)
|
44 (40 to 50)
|
0.0002
|
|
African ethnicity
|
6 (25)
|
11 (14.5)
|
26 (28.6)
|
34 (36.6)
|
0.01
|
|
Co-morbidities
| | | | | |
|
Hepatic cirrhosis
|
1 (4.2)
|
11 (14.5)
|
10 (11)
|
6 (6.4)
|
0.24
|
|
Chronic hepatitis C infection
|
2 (8.3)
|
19 (25)
|
23 (25.3)
|
12 (12.9)
|
0.03
|
|
Chronic hepatitis B infection
|
3 (12.5)
|
16 (21)
|
15 (16.5)
|
16 (17.2)
|
0.76
|
|
Homeless
|
0
|
4 (5.3)
|
8 (8.8)
|
14 (15)
|
0.05
|
|
HIV-related characteristics
| | | | | |
|
Time from diagnosis (months)
|
46 (2 to 125)
|
70 (3 to 147)
|
74 (6 to 135)
|
81 (6 to 170)
|
0.42
|
|
HAART administrationa
|
9 (37.5)
|
40 (52.6)
|
52 (57.1)
|
49 (52.7)
|
0.39
|
|
New HIV diagnosisb
|
6 (25)
|
17 (22.4)
|
18 (20.2)
|
15 (17)
|
0.77
|
|
CD4+ cell count >200/mm3
|
6 (26.1)
|
26 (35.1)
|
23 (27.7)
|
30 (36.1)
|
0.55
|
|
Direct admission to the ICU
|
16 (66.7)
|
31 (40.8)
|
40 (44)
|
44 (47.3)
|
0.15
|
|
Main reason for ICU admissions
| | | | | |
|
Sepsis
|
7 (29.2)
|
15 (19.7)
|
23 (25.3)
|
23 (24.7)
|
0.74
|
|
Bacterial pneumonia
|
7 (29.2)
|
25 (32.9)
|
32 (35.2)
|
30 (32.3)
|
0.94
|
|
Pneumocystis pneumonia
|
4 (16.7)
|
17 (22.4)
|
14 (15.4)
|
18 (19.3)
|
0.69
|
|
Cerebral toxoplasmosis
|
1 (4.2)
|
4 (5.3)
|
5 (5.5)
|
6 (6.4)
|
0.97
|
|
SAPS II
|
53 (33 to 60)
|
44 (31 to 57)
|
46 (32 to 55)
|
48 (35 to 61)
|
0.44
|
|
Life-supporting procedures
| | | | | |
|
Mechanical ventilation
|
14 (58.3)
|
38 (50)
|
40 (44)
|
32 (34.4)
|
0.08
|
|
Renal replacement therapy
|
3 (12.5)
|
8 (10.5)
|
13 (14.3)
|
7 (7.5)
|
0.52
|
|
Vasopressors
|
8 (33.3)
|
18 (23.7)
|
21 (23)
|
17 (18.3)
|
0.46
|
|
ICU mortality
|
6 (25)
|
13 (17.1)
|
12 (13.2)
|
8 (8.6)
|
0.01
|
